Intervention

lumbar puncture

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions6

Lead sponsors shown3

Clinical trials

3 shown

Biomarkers of Synaptic Damage in Multiple SclerosisNCT03217396 · 2017-11-22

ANCILLARY STUDY No. 3 NS-PARK-OMICSNCT07832461 · 2026-10-15

NOT_YET_RECRUITING

Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.NCT01876459 · 2013-04-01

Common conditions

"Alzheimer's Disease" and "Lewy Body Disease"1 Alzheimer Disease1 Amyotrophic Lateral Sclerosis1 Multiple Sclerosis1 Parkinson Disease1 PARKINSON DISEASE (Disorder)1

Leading sponsors

Institut National de la Santé Et de la Recherche Médicale, France1 Neuromed IRCCS1 University Hospital, Strasbourg, France1

Trial status mix

NOT_YET_RECRUITING1

RECRUITING1

UNKNOWN1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.